申请人:SCHERING CORPORATION
公开号:EP0330004A1
公开(公告)日:1989-08-30
Compounds having an optionally-substituted purine derivative portion and a carbobicyclic or heterobicyclic portion, which compounds are useful as phosphodiesterase inhibitors, are disclosed. Also disclosed are intermediates, methods for making the inhibitors, pharmaceutical compositions and methods for treating hypertension using the compounds.
本发明公开了具有任选取代的嘌呤衍生物部分和碳双环或杂双环部分的化合物,这些化合物可用作磷酸二酯酶抑制剂。还公开了中间体、制造抑制剂的方法、药物组合物以及使用这些化合物治疗高血压的方法。